ABOVE L-R: The signing marked the official opening of Cath lab. Dr Chong Yoon Sin, Consultant Cardiologist; Elaine Cheong, CEO-Malaysia of Ramsay Sime Darby Health Care; Dr Maxim Mamin, Senior Vice President & Head of Siemens Healthcare Malaysia;Dato Dr Jacob homas, Chairman of Ramsay Sime Darby Health Care Group; Dr Chua Seng Keong, Consultant Cardiologist & Ms Ch’ng Lin Ling, Hospital CEO of ParkCity Medical Centre. Premier Bintaro helps with surgery for the disadvantaged In December 2014, Premier Bintaro performed 17 herniotomies and 13 cleft lip and palates for disadvantaged children from West Java. This service was supported by two general surgeons and two plastic & reconstruction surgeons. Premier Bintaro Hospital has been in collaboration with OBI Foundation, a non-profit organization which assists poor people who need surgery, for six years. Premier Surabaya opens new Stroke Unit On the 1 December 2014 RS Premier Surabaya opened their nine bed Stroke Unit. The new Stroke Unit is providing a backup for ICU/ICCU and High Care Unit patients. Know someone in nursing who deserves an award? RAMSAYSIMEDARBY The Ramsay Way - 2015 | 01 9 Park City Medical Centre benefits from new cardiac equipment Ramsay Sime Darby’s ParkCity Medical Centre has become the first hospital in Malaysia to invest in the advanced interventional innovation from Siemens Healthcare – the ceiling mounted Siemens Artis Q angiography system. The recent installation of the Siemens Artis Q technology into their new cardiac catheter laboratory at the ParkCity Medical Centre now provides the infrastructure for the Centre to grow in structural heart disease and endovascular surgery, facilitating the latest techniques, procedures and devices in these fields. The Artis Q angiography system for interventional imaging is a visionary breakthrough in X-ray generation and detection that takes performance and precision to the next level. It features new X-ray tube and detector technology designed to improve minimally invasive therapy of diseases such as coronary heart disease (CAD), stroke and cancer. The device can help clinicians identify small vessels up to 70% better than conventional X-ray tube technology as it uses a unique GIGALIX flat emitter instead of coiled filament traditionally found within X-ray tubes, allowing the lowest appropriate dose to be achieved plus provide fine focal spot sizes and grid pulse technology. This protects patients, doctors and medical staff, especially during longer interventions. The system also includes a unique water cooled 16-bit detector, which provides 4 times the depth resolution, when compared to conventional 14-bit detectors resulting in soft-tissue contrast. The Artis Q angiography system was selected due to its excellent image quality following comprehensive evaluation of other systems available on the market. With its ability to visualize tiny blood vessels and devices, it will allow clinicians to provide a highly accurate service for complex conditions. “The opening of our catheterization lab is significant for our communities,” said Ch’ng Lin Ling, Hospital CEO of ParkCity Medical Centre. “Cardiovascular disease remains one of the top medical concerns in our country and our new catheter lab will help with the diagnosis and management of this disease,” she said. “The new cath lab will provide a higher level of accessibility and precision for our doctors when treating and managing heart condition. “For the patient, having equipment with ultralow radiation dose, enhanced visibility for small vessels and high quality images allows the cardiologist to see real-time clear stent. ParkCity Medical Centre has raised the bar in providing treatment for interventional cardiac procedures. “ParkCity Medical Center prides itself on providing its patients with the latest innovative technology. The installation of this state-of-the-art equipment supports the Centre’s commitment to improving the health outcomes for the cardiac patients in our community.” Premier Jatinegrara successful in JCI reaccreditation After a five days of survey, by the Joint Commission International (JCI) surveyors. Premier Jatinegara Hospital was successfully reaccredited by JCI on the 19 December 2014. JCI is an independent organization which specifically evaluates and accredits healthcare organizations throughout the world with International standards. These standards cover both Clinical and Non Clinical areas. CEO Dr. Handojo Rahardjo paid tribute to all Doctors and Staff for their hard work in achieving excellent survey results and their ongoing commitment to patient safety. Recognise their outstanding leadership and innovation by nominating them in one of three categories: NOMINATE hestaawards.com.au *Generously supported by: Proudly presented by: 2014 winners, left to right: Zoe Sabri, Stephen Brown and Prof Jeanine Young. Issued by H.E.S.T. Australia Ltd ABN 66 006 818 695 AFSL No. 235249 Trustee of Health Employees Superannuation Trust Australia (HESTA) ABN 64 971 749 321. Terms and conditions apply. See hestanursingawards.com.au for details. $30,000in prizes to be won!* Nurse of the Year Team Innovation Outstanding Graduate NOW! 1477.HANA2015_250x86.indd 1 2/03/15 11:44 AM
The Ramsay Way - Autumn 2015
To see the actual publication please follow the link above